Results showed that the majority of ETP-ALL cases (83%) did not show BCL11B expression, while the majority of non-ETP-ALL/LBL cases (84%) showed positive BCL11B expression. This evidence concerns the gene BCL11B and acute lymphoblastic leukemia.